Enkephalinase-inhibitors modulate immune responses

References

• Algeri S., Altstein M., De Simone G. M., Guardabasso V. In vivo potentiation of (D-Ala) Met-enkephalin amide central effects after administration of an enkephalinase inhibitor. European Journal of Pharmacology 1981; 74: 261–262
   PubMed Web of Science ®Google Scholar
• Chaillet P., Marcais-Collado H., Costentin J., Yi C.-C., De La Baume S., Schwartz J.-C. Inhibition of enkephalin metabolism by, and antinociceptive activity of, bestatin, an aminopeptidase inhibitor. European Journal of Pharmacology 1983; 86: 329–336
   PubMed Web of Science ®Google Scholar
• Dupont A., Cusan L., Garon M., Alvarando-Urbina G., Labrie F. Extremely rapid degradation of (3H) methionine-enkephalin by various rat tissues in vivo and in vitro. Life Sciences 1977; 21: 907–916
   PubMed Web of Science ®Google Scholar
• Dyer S. H., Slaughter C. A., Orth K., Moomaw C. R., Hersh L. Comparison of the soluble and membrane-bound forms of the puromycin-sensitive enkephalin-degrading aminopeptidases from rat. Journal of Neurochemistry 1990; 54: 547–554
   PubMed Web of Science ®Google Scholar
• Fournie-Zaluski M.-C., Soroca-Lucas E., Waksman G., Llorens C., Schwartz J.-C., Roques B. P. Differential recognition of “enkephalinase” and angiotensin-converting enzyme by new carboxyalkyl inhibitors. Life Sciences 1982; 31: 2947–2954
   PubMed Web of Science ®Google Scholar
• Gorenstein C., Snyder S. Two distinct enkephalinases; solubilization, partial purification and separation from angiotensin converting enzyme. Life Sciences 1979; 25: 2065–2070
   PubMed Web of Science ®Google Scholar
• Hachisu M., Hiranuma T., Murata S., Aoyagi T., Umezawa H. Analgesic effect of actinonin, a new inhibitor of multiple enkephalin degrading enzymes. Life Sciences 1987; 41: 235–240
   PubMed Web of Science ®Google Scholar
• Hachisu M., Hiranuma T., Shibazaki Y., Uotani K., Murata S., Aoyagi T., Umezawa H. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes. European Journal of Pharmacology 1987; 137: 59–65
   PubMed Web of Science ®Google Scholar
• Hambrook J. M., Morgan B. A., Rance M. J., Smith C. F. C. Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 1976; 262: 782–783
   PubMed Web of Science ®Google Scholar
• Hudgin R. L., Charleson S. E., Zimmerman M., Mumford R., Wood P. L. Enkephalinase; selective peptide inhibitors. Life Sciences 1981; 29: 2593–2601
   PubMed Web of Science ®Google Scholar
• Janković B. D., Marić D. Modulation of in vivo immune response by enkephalins. Clinical Neuropharmacology 1986; 9: 476–478, (Suppl.)
   PubMed Web of Science ®Google Scholar
• Janković B. D., Maric D. Enkephalins and immunity. I. In vivo suppression and potentiation of humoral immune response. Annals of the New York Academy of Sciences 1987; 496: 115–125
   PubMed Web of Science ®Google Scholar
• Janković B. D., Maric D., Veljić J. Cerebrally mediated modulation of anaphylactic shock by methionine-enkephalin. International Journal of Neuroscience 1990; 51: 193–194
   PubMed Web of Science ®Google Scholar
• Janković B. D., Veljić J. (in press). Brain, enkephalins and immunity; modulation of immune responses by methionine-enkephalin injected into lateral ventricles of the rat brain. Neuro-Psycho-Immunology; Recent research, B. D. Janković, B. M. Markovi. Gordon and Breach Publishers, Inc, Philadelphia
   Google Scholar
• Koshiya K., Kato T., Tanaka R., Kato T. Brain peptidases: their possible neural and glial localization. Brain Research 1984; 324: 261–270
   PubMed Web of Science ®Google Scholar
• Llorens-Cortes C., Gros C., Schwartz J.-C. Study of endogenous Tyr-Gly-Gly, a putative enkephalin metabolite, in mouse brain: validation of a radioimmunoassay, localization and effects of peptidase inhibitors. European Journal of Pharmacology 1985; 119: 183–191
   PubMed Web of Science ®Google Scholar
• Mansour A., Khachaturian H., Lewis M. E., Watson S. J. Autoradiographic differentiation of mu, delta and kappa opioid receptors in the rat forebrain and midbrain. Journal of Neuroscience 1987; 7: 2445–2464
   PubMed Web of Science ®Google Scholar
• McKnight A. T., Corbett A. D., Kosterlitz H. W. Increase in potencies of opioid peptides after peptidase inhibition. European Journal of Pharmacology 1983; 86: 393–402
   PubMed Web of Science ®Google Scholar
• Meek J. L., Yang H.-Y. T., Costa E. Enkephalin metabolism in vitro and in vivo. Neuropharmacology 1977; 16: 151–154
   PubMed Web of Science ®Google Scholar
• Miller R. J., Cuatrecasas P. Enkephalins and endorphins. Vitamins and hormones, P. L. Munson, J. Glover, E. Diezfalusy, R. E. Olson. Academic Press, New York 1978; Vol. 36: 297–282
   Google Scholar
• Murthy L. R., Glick S. D., Almenoff J., Wilk S., Orlowski M. Inhibitors of an enkephalin degrading membrane-bound metalloendopeptidase: analgesic properties and effects on striatal enkephalin levels. European Journal of Pharmacology 1984; 102: 305–313
   PubMed Web of Science ®Google Scholar
• Pert C., Pert A., Chang J. (D-Ala)-met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. Science 1976; 194: 330–332
   PubMed Web of Science ®Google Scholar
• Roscetti G., Possenti R., Bassano E., Roda L. G. Mechanisms of leu-enkephalin hydrolysis in human blood. Life Sciences 1984; 45: 193–197
   Google Scholar
• Udenfriend S., Meienhofer J. The peptides: analysis, synthesis and biology. Academic Press, London 1984
   Google Scholar
• Veljić J., Marić D., Janković B. D. Effect of intracerebroventricularly injected methionine-enkephalin on humoral immune response in the rat. Periodicum Biologorum 1990; 92: 73–74
   Web of Science ®Google Scholar
• Wagner G. W., Dickson J. E. Inhibitors of a rat brain enkephalin aminopeptidase. Journal of Neurochemistry 1981; 37: 709–713
   PubMed Web of Science ®Google Scholar